Search results for: Value-Based Pricing

Early Diagnosis of Visual Defects

1 July 1967

…based entirely on the reduction of intra-ocular pressure. Detection of the disease is frequently by measurement of this pressure by tonometry, but this presents problems in that it is not…

Is There a Productivity Crisis in Pharmaceutical R&D?

6 January 2012

…changes in both the regulatory and marketing climates. In addition to describing overall trends, Prof Riccaboni also compares the R&D performance of companies based in the US and Europe, and…

Policy, Organisation and Incentives in Health Systems

…certain behaviours and outcomes. The broader socioeconomic value of health interventions to the wider economy, with a particular focus on prevention (including vaccination). Key objective for this research theme To produce…

OHE to host the Health Economists’ Study Group Summer 2025

6 March 2025

…Health Economists’ Study Group (HESG) is the oldest organisation of its type in health economics and exists to support and promote the work of health economists. HESG is based in…

Medicines, Health and the Poor World

1 April 1982

…allocation in most developing countries was too heavily biased towards urban, hospital based, curative medicine, OHE noted that in many poor countries two thirds to three quarters of public health…

Costs and Benefits of Regulating New Product Development in the UK Pharmaceutical Industry

3 January 1982

…The first concerned prices; this second paper is concerned, by contrast, with the costs of pharmaceutical innovation. This study by Keith Hartley and Alan Maynard is based on a survey…

Needs of the Pharmaceutical Manufacturers from Their Medical Departments in the 1980s

1 February 1983

…the Directors of several individual Medical Departments in Britain, on whose expertise the study is based. The conclusions and predictions are, however, my own responsibility. I trust they may be…

Issues in Development: a Guide

5 January 1983

…them. Dr Leisinger stresses the need to utilise technologically based contributions to development prudently; that is in a manner compatible with the social and cultural conditions prevailing in each less…

Consumer Movement, Health, and the Pharmaceutical Industry

1 January 1983

…deny the value of extensive legal and financial interventions designed to protect those in need of care and support from the hazards of an untrammelled market. Yet at the same…